文献速递主动脉疾病

2004至2015年美国腹主动脉瘤开放与腔内修复的流行病学及筛查启示

Epidemiology of endovascular and open repair for abdominal aortic aneurysms in the United States from 2004 to 2015 and implications for screening.
PubMed 文献 · J Vasc Surg · 2021-02-14

基于美国全国住院患者样本2004至2015年数据,共评估65,125例破裂腹主动脉瘤入院和461,191例完整腹主动脉瘤修复。约68%破裂入院患者和59%破裂修复患者不符合现有筛查标准,其中63%年龄>75岁、24%年龄<65岁、36%为女性。EVAR在破裂和完整腹主动脉瘤修复中均显著增加,院内死亡率分别为35%和2.0%,提示应考虑扩大筛查标准以纳入部分女性和更宽年龄范围。

要点

  • 多数破裂腹主动脉瘤修复患者不符合现行筛查标准,主要因年龄>75岁、<65岁或为女性。
  • EVAR已成为破裂和完整腹主动脉瘤的主要治疗方式,比例分别从2004年10%和45%升至2015年55%和83%。
  • 破裂腹主动脉瘤修复院内死亡率为35%,完整腹主动脉瘤修复为2.0%。

核心结论

  • 大多数接受破裂腹主动脉瘤修复的患者不符合现有筛查标准,应考虑扩大筛查标准以纳入部分女性和更宽年龄范围。

研究设计与样本

  • 基于美国全国住院患者样本(National Inpatient Sample)2004至2015年的回顾性分析,使用ICD编码识别破裂和完整腹主动脉瘤入院及修复。
  • 共评估65,125例破裂腹主动脉瘤入院和461,191例完整腹主动脉瘤修复。
  • 筛查合格队列按既往比例(男性吸烟者87%、所有家族史患者10%)应用于65至75岁患者,并考虑17%可能既往已诊断腹主动脉瘤者。

主要发现

  • 估计45,037例(68%)破裂腹主动脉瘤入院患者和25,777例(59%)破裂腹主动脉瘤修复患者不符合筛查标准。
  • 不符合筛查标准的患者中,27,653例(63%)年龄>75岁,10,603例(24%)年龄<65岁,16,103例(36%)为女性。
  • 破裂腹主动脉瘤EVAR从2004年10%增至2015年55%(P < .001),手术死亡率为35%。
  • 完整腹主动脉瘤EVAR从2004年45%增至2015年83%(P < .001),手术死亡率为2.0%。

关键数值与推荐

  • 现行筛查覆盖65至75岁有腹主动脉瘤家族史的患者以及有吸烟史的男性。
  • 筛查合格队列基于男性吸烟者87%和所有家族史患者10%的比例应用于65至75岁患者。
  • 考虑17%可能既往已诊断腹主动脉瘤(来自筛查或>75岁患者偶然发现)。

临床怎么用

  • 血管外科医生应认识到多数破裂腹主动脉瘤修复患者不符合现行筛查标准,需关注扩大筛查标准以覆盖女性和更宽年龄范围。
  • EVAR是破裂和完整腹主动脉瘤的主要治疗方式,院内死亡率分别为35%和2.0%。

局限性

  • 筛查合格队列基于既往比例估算,而非直接个体数据。
  • 使用行政数据库ICD编码识别病例,可能存在编码不准确。
  • 回顾性设计,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contemporary national trends in the repair of ruptured abdominal aortic aneurysms (AAAs) and intact AAAs are relatively unknown. Furthermore, screening is only covered by insurance for patients aged 65 to 75 years with a family history of AAAs and for men with a positive smoking history. It is unclear what proportion of patients who present with a ruptured AAA would have been candidates for screening. METHODS: Using the National Inpatient Sample from 2004 to 2015, we identified ruptured and intact AAA admissions and repairs using the International Classification of Diseases codes. We generated the screening-eligible cohort using previously identified proportions of male smokers (87%) and all patients with a family history of AAAs (10%) and applied these proportions to patients aged 65 to 75 years. We accounted for those who could have had a previous AAA diagnosis (17%), either from screening or an incidental detection in patients aged >75 years who had presented with AAA rupture. The primary outcomes were treatment and in-hospital mortality between patients meeting the criteria for screening vs those who did not. RESULTS: We evaluated 65,125 admissions for ruptured AAAs and 461,191 repairs for intact AAAs. Overall, an estimated 45,037 admitted patients (68%) and 25,777 patients who had undergone repair for ruptured AAAs (59%) did not meet the criteria for screening. Of the patients who did not qualify, 27,653 (63%) were aged >75 years, 10,603 (24%) were aged <65 years, and 16,103 (36%) were women. Endovascular AAA repair (EVAR) increased for ruptured AAAs from 10% in 2004 to 55% in 2015 (P < .001), with operative mortality of 35%. EVAR increased for intact AAAs from 45% in 2004 to 83% in 2015 (P < .001), with operative mortality of 2.0%. CONCLUSIONS: Most patients who had undergone repair for ruptured AAAs did not qualify for screening. EVAR was the primary treatment of both ruptured and intact AAAs with relatively low in-hospital mortality. Therefore, expansion of the screening criteria to include selected women and a wider age range should be considered.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dansey KD, Varkevisser RRB, Swerdlow NJ, et al. Epidemiology of endovascular and open repair for abdominal aortic aneurysms in the United States from 2004 to 2015 and implications for screening. J Vasc Surg. 2021. PMID: 33592293. doi:10.1016/j.jvs.2021.01.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。